1515 — China Resources Medical Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Market Cap
HK$3.75bn
Enterprise Value
HK$5.18bn
Revenue
CNY9.18bn

Annual income statement for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,447	7,901	10,108	9,855	9,176
Cost of Revenue
Gross Profit	934	1,306	1,906	1,810	1,441
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,237	7,495	9,574	9,039	8,457
Operating Profit	210	406	534	815	719
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	270	423	493	839	748
Provision for Income Taxes
Net Income After Taxes	426	328	328	672	556
Minority Interest
Net Income Before Extraordinary Items
Net Income	418	266	258	566	496
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	418	266	258	566	496
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.446	0.291	0.458	0.48	0.404
Dividends per Share